EVGN logo

Evogene (EVGN) EBITDA

Annual EBITDA

-$23.26 M
+$3.75 M+13.88%

December 31, 2023

Summary

Performance

1-Year Change

+13.88%

3-Year Change

-0.22%

5-Year Change

-23.97%

15-Year Change

-24.5%

EVGN EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

49.07%
EVGN annual EBITDA is higher than 49.07% of companies in Healthcare sector

High & Low

All-time High

-$1.29 M

3-Year Low

-$27.88 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
EVGN previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 7, 2025
EVGN next annual earnings announcement is scheduled for Mar 7, 2025

OtherEVGNprofitabilitymetrics:

Annual Revenue

$5.64 M
EVGN annual revenue is $5.64 million

Annual Net Income

-$23.88 M
EVGN annual net profit is -$23.88 million

Annual EBIT

-$25.87 M
EVGN annual earnings before interest & taxes is -$25.87 million

Annual EPS

-$5.20
EVGN annual earnings per share is -$5.20

Quarterly EBITDA

-$4.68 M
+$568.00 K+10.82%

September 1, 2024

Summary

Performance

3-Month Change

+10.82%

1-Year Change

-51.34%

3-Year Change

+27.63%

5-Year Change

-17.29%

EVGN Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

48.81%
EVGN quarterly EBITDA is higher than 48.81% of companies in Healthcare sector

High & Low

All-time High

$383.00 K
EVGN quarterly EBITDA is currently -1322.19% below its historical high of $383.00 thousand

3-Year Low

-$8.30 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
EVGN previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

Mar 7, 2025
EVGN next earnings announcement is scheduled for Mar 7, 2025

OtherEVGNprofitabilitymetrics:

Quarterly Revenue

$1.80 M
EVGN quarterly revenue is $1.80 million

Quarterly Net Income

-$7.63 M
EVGN quarterly net profit is -$7.63 million

Quarterly EBIT

-$5.31 M
EVGN quarterly earnings before interest & taxes is -$5.31 million

Quarterly EPS

-$1.31
EVGN quarterly earnings per share is -$1.31

TTM EBITDA

-$20.39 M
-$1.59 M-8.44%

September 1, 2024

Summary

Performance

3-Month Change

-8.44%

1-Year Change

+8.42%

3-Year Change

+24.49%

5-Year Change

-2.53%

EVGN TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

49.41%
EVGN TTM EBITDA is higher than 49.41% of companies in Healthcare sector

High & Low

All-time High

-$546.00 K

3-Year Low

-$30.21 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
EVGN previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

Mar 7, 2025
EVGN next earnings announcement is scheduled for Mar 7, 2025

OtherEVGNprofitabilitymetrics:

TTM Revenue

$7.48 M
EVGN TTM revenue is $7.48 million

TTM Net Income

-$23.51 M
EVGN TTM net profit is -$23.51 million

TTM EBIT

-$22.97 M
EVGN TTM earnings before interest & taxes is -$22.97 million

TTM EPS

-$4.43
EVGN TTM earnings per share is -$4.43

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

-$23.26 M
EVGN annual EBITDA is -$23.26 million

Annual Net Income

-$23.88 M
EVGN annual net profit is -$23.88 million

Annual Interest Expense

$115.00 K
EVGN annual interest expense is $115.00 thousand

Annual Income Tax

-$33.00 K
EVGN annual income tax is -$33.00 thousand

Annual D&A

$2.61 M
EVGN annual depreciation & amortization is $2.61 million

EVGN EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+13.9%-51.3%+8.4%
3 y3 years-0.2%+27.6%+24.5%
5 y5 years-24.0%-17.3%-2.5%

EVGN EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+16.6%-55.6%+43.6%-8.4%+32.5%
5 y5-year-45.2%+16.6%-55.6%+45.1%-27.3%+32.5%
alltimeall time-1701.7%+16.6%-1322.2%+45.1%-3635.3%+32.5%

Evogene EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
-$4.68 M(-10.8%)
-$20.39 M(+8.4%)
Jun 2024
-
-$5.25 M(+74.5%)
-$18.81 M(-7.9%)
Mar 2024
-
-$3.01 M(-59.7%)
-$20.42 M(-12.2%)
Dec 2023
-$23.26 M(-13.9%)
-$7.46 M(+141.1%)
-$23.26 M(+4.4%)
Sep 2023
-
-$3.09 M(-54.9%)
-$22.27 M(-12.4%)
Jun 2023
-
-$6.86 M(+17.4%)
-$25.44 M(-0.3%)
Mar 2023
-
-$5.85 M(-9.6%)
-$25.52 M(-5.5%)
Dec 2022
-$27.01 M(-3.1%)
-$6.47 M(+3.4%)
-$27.01 M(-6.4%)
Sep 2022
-
-$6.26 M(-10.0%)
-$28.84 M(-4.5%)
Jun 2022
-
-$6.95 M(-5.2%)
-$30.21 M(+2.2%)
Mar 2022
-
-$7.33 M(-11.7%)
-$29.57 M(+6.0%)
Dec 2021
-$27.88 M(+20.1%)
-$8.30 M(+8.8%)
-$27.88 M(-0.8%)
Sep 2021
-
-$7.63 M(+20.9%)
-$28.11 M(+12.0%)
Jun 2021
-
-$6.31 M(+11.7%)
-$25.11 M(+10.2%)
Mar 2021
-
-$5.65 M(-33.8%)
-$22.79 M(-1.8%)
Dec 2020
-$23.21 M(+44.9%)
-$8.53 M(+84.7%)
-$23.21 M(+10.4%)
Sep 2020
-
-$4.62 M(+15.8%)
-$21.03 M(+5.7%)
Jun 2020
-
-$3.99 M(-34.2%)
-$19.89 M(+3.3%)
Mar 2020
-
-$6.07 M(-4.5%)
-$19.26 M(+20.2%)
Dec 2019
-$16.02 M(-14.6%)
-$6.35 M(+82.5%)
-$16.02 M(-2.4%)
Sep 2019
-
-$3.48 M(+3.8%)
-$16.41 M(-4.6%)
Jun 2019
-
-$3.35 M(+18.5%)
-$17.20 M(-2.7%)
Mar 2019
-
-$2.83 M(-58.0%)
-$17.68 M(-5.8%)
Dec 2018
-$18.76 M
-$6.74 M(+58.0%)
-$18.76 M(+3.3%)
Sep 2018
-
-$4.27 M(+11.4%)
-$18.17 M(-0.7%)
DateAnnualQuarterlyTTM
Jun 2018
-
-$3.83 M(-2.1%)
-$18.30 M(-1.6%)
Mar 2018
-
-$3.92 M(-36.3%)
-$18.61 M(-0.4%)
Dec 2017
-$18.68 M(-0.7%)
-$6.15 M(+39.5%)
-$18.68 M(-8.7%)
Sep 2017
-
-$4.41 M(+6.5%)
-$20.46 M(+0.1%)
Jun 2017
-
-$4.14 M(+3.6%)
-$20.45 M(+1.5%)
Mar 2017
-
-$3.99 M(-49.6%)
-$20.14 M(+7.1%)
Dec 2016
-$18.81 M(+21.4%)
-$7.92 M(+80.3%)
-$18.81 M(+6.2%)
Sep 2016
-
-$4.39 M(+14.6%)
-$17.72 M(+12.5%)
Jun 2016
-
-$3.83 M(+44.2%)
-$15.76 M(+0.9%)
Mar 2016
-
-$2.66 M(-61.1%)
-$15.62 M(+0.8%)
Dec 2015
-$15.49 M(+19.1%)
-$6.83 M(+181.0%)
-$15.49 M(+6.1%)
Sep 2015
-
-$2.43 M(-34.3%)
-$14.60 M(-4.5%)
Jun 2015
-
-$3.70 M(+46.3%)
-$15.29 M(+8.6%)
Mar 2015
-
-$2.53 M(-57.5%)
-$14.08 M(+8.2%)
Dec 2014
-$13.01 M(+94.7%)
-$5.94 M(+90.6%)
-$13.01 M(+12.9%)
Sep 2014
-
-$3.12 M(+25.3%)
-$11.52 M(+13.5%)
Jun 2014
-
-$2.49 M(+70.9%)
-$10.15 M(+20.7%)
Mar 2014
-
-$1.46 M(-67.3%)
-$8.41 M(+28.0%)
Dec 2013
-$6.68 M(+417.4%)
-$4.46 M(+155.0%)
-$6.57 M(+94.8%)
Sep 2013
-
-$1.75 M(+133.4%)
-$3.37 M(+75.3%)
Jun 2013
-
-$749.00 K(-295.6%)
-$1.92 M(+11.8%)
Mar 2013
-
$383.00 K(-130.4%)
-$1.72 M(-18.2%)
Dec 2012
-$1.29 M(-26.8%)
-$1.26 M(+321.1%)
-$2.10 M(+149.0%)
Sep 2012
-
-$299.00 K(-45.2%)
-$845.00 K(+54.8%)
Jun 2012
-
-$546.00 K
-$546.00 K
Dec 2011
-$1.76 M
-
-

FAQ

  • What is Evogene annual EBITDA?
  • What is the all time high annual EBITDA for Evogene?
  • What is Evogene annual EBITDA year-on-year change?
  • What is Evogene quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Evogene?
  • What is Evogene quarterly EBITDA year-on-year change?
  • What is Evogene TTM EBITDA?
  • What is the all time high TTM EBITDA for Evogene?
  • What is Evogene TTM EBITDA year-on-year change?

What is Evogene annual EBITDA?

The current annual EBITDA of EVGN is -$23.26 M

What is the all time high annual EBITDA for Evogene?

Evogene all-time high annual EBITDA is -$1.29 M

What is Evogene annual EBITDA year-on-year change?

Over the past year, EVGN annual EBITDA has changed by +$3.75 M (+13.88%)

What is Evogene quarterly EBITDA?

The current quarterly EBITDA of EVGN is -$4.68 M

What is the all time high quarterly EBITDA for Evogene?

Evogene all-time high quarterly EBITDA is $383.00 K

What is Evogene quarterly EBITDA year-on-year change?

Over the past year, EVGN quarterly EBITDA has changed by -$1.59 M (-51.34%)

What is Evogene TTM EBITDA?

The current TTM EBITDA of EVGN is -$20.39 M

What is the all time high TTM EBITDA for Evogene?

Evogene all-time high TTM EBITDA is -$546.00 K

What is Evogene TTM EBITDA year-on-year change?

Over the past year, EVGN TTM EBITDA has changed by +$1.88 M (+8.42%)